Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Eiger BioPharmaceuticals Inc (NASDAQ:EIGR)

11.80
Delayed Data
As of Dec 07
 -0.85 / -6.72%
Today’s Change
10.71
Today|||52-Week Range
25.80
-46.49%
Year-to-Date
No recent news for Eiger BioPharmaceuticals Inc.

Today’s Trading

Previous close12.65
Today’s open12.70
Day’s range11.70 - 12.70
Volume18,027
Average volume (3 months)27,860
Market cap$105.7M
Dividend yield--
Data as of 3:59pm ET, 12/07/2016

Growth & Valuation

Earnings growth (last year)-2.31%
Earnings growth (this year)+74.99%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book0.64

Competitors

 Today’s
change
Today’s
% change
--Innovative Pharmaceu...+0.00+4.41%
PRQRProQR Therapeutics N...+0.05+1.14%
GTXIGTX Inc-0.27-3.95%
KURAKura Oncology Inc+0.20+3.92%
Data as of 3:59pm ET, 12/07/2016

Financials

Next reporting dateMarch 1, 2017
EPS forecast (this quarter)-$1.36
Annual revenue (last year)$0.00
Annual profit (last year)-$44.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
David A. Cory
Chief Financial Officer
James H. Welch
Corporate headquarters
Palo Alto, California

Forecasts


Search for Jobs